Skip to main content
eScholarship
Open Access Publications from the University of California

Reprint of: Prevention and Treatment of Tobacco Use: JACC Health Promotion Series.

  • Author(s): Kalkhoran, Sara
  • Benowitz, Neal L
  • Rigotti, Nancy A
  • et al.

Published Web Location

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261256/pdf/nihms-1506688.pdf
No data is associated with this publication.
Creative Commons 'BY-NC-SA' version 4.0 license
Abstract

Tobacco use is the leading preventable cause of death worldwide and is a major risk factor for cardiovascular disease (CVD). Both prevention of smoking initiation among youth and smoking cessation among established smokers are key for reducing smoking prevalence and the associated negative health consequences. Proven tobacco cessation treatment includes pharmacotherapy and behavioral support, which are most effective when provided together. First-line medications (varenicline, bupropion, and nicotine replacement) are effective and safe for patients with CVD. Clinicians who care for patients with CVD should give as high a priority to treating tobacco use as to managing other CVD risk factors. Broader tobacco control efforts to raise tobacco taxes, adopt smoke-free laws, conduct mass media campaigns, and restrict tobacco marketing enhance clinicians' actions working with individual smokers.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Item not freely available? Link broken?
Report a problem accessing this item